Overview

A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

Status:
Completed

Trial end date:
2019-11-22

Target enrollment:

Participant gender:

Summary

A Multi-Center, Phase 2, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution (0.25% Novel Formulation) Compared to Vehicle in Subjects with Dry Eye Disease

Phase:

Phase 2

Details

Lead Sponsor:

Aldeyra Therapeutics, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions